Columnist Betty Vertin recognizes the admirable traits in those living with Duchenne muscular dystrophy — and their moms.

Treatment with preventive heart medications can extend survival among males with Duchenne muscular dystrophy (DMD), a new ...

The FDA has lifted its hold and has given Entrada Therapeutics permission to launch a Phase 1b clinical trial to test ...

Five oculopharyngeal muscular dystrophy (OPMD) patients have now been treated with the gene therapy candidate BB-301 in a ...

People with Duchenne or Becker muscular dystrophy who had more siblings typically report being better prepared to transition ...

Reflecting on his sudden hospitalization last year, columnist Patrick Moeschen emphasizes the need to create an emergency medical plan.

Columnist Betty Vertin, overwhelmed by caregiving duties and decisions, sometimes feels like she's walking a tightrope.

The U.S. Food and Drug Administration (FDA) has given Entrada Therapeutics permission to launch a Phase 1b clinical trial to test ENTR-601-44, the company’s experimental exon-skipping therapy, in ...

Betty Vertin is a mother and writer living in rural Hastings, Nebraska, with her husband and seven children. Betty is a caregiver to three sons, Max, Rowen, and Charlie. Her oldest was diagnosed with ...